JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M212546200 on December 16, 2002

J. Biol. Chem., Vol. 278, Issue 8, 5894-5901, February 21, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/8/5894    most recent
M212546200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cao, S.
Right arrow Articles by Shah, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cao, S.
Right arrow Articles by Shah, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Proline-rich Domain of Dynamin-2 Is Responsible for Dynamin-dependent in Vitro Potentiation of Endothelial Nitric-oxide Synthase Activity via Selective Effects on Reductase Domain Function*

Sheng CaoDagger , Janet YaoDagger , and Vijay ShahDagger §

From the Dagger  Gastrointestinal Research Unit and Department of Medicine and the § Tumor Biology Program, Mayo Clinic, Rochester, Minnesota 55905

The GTPase dynamin-2 (dyn-2) binds and positively regulates the nitric oxide-generating enzyme, endothelial nitric-oxide synthase (eNOS) (Cao, S., Yao, Y., McCabe, T., Yao, Q., Katusic, Z., Sessa, W., and Shah, V. (2001) J. Biol. Chem. 276, 14249-14256). Here we demonstrate, using purified proteins, that this occurs through a selective influence of the dyn-2 proline-rich domain (dyn-2 PRD) on the eNOS reductase domain. In vitro studies demonstrate that dyn-2 PRD fused with glutathione S-transferase (GST) binds recombinant eNOS protein specifically and with binding kinetics comparable with that observed between dyn-2 full-length and eNOS. Additionally, GST-dyn-2 PRD binds the in vitro transcribed 35S-eNOS reductase domain but not the 35S-eNOS oxygenase domain. Furthermore GST-dyn-2 PRD binds a 35S-labeled eNOS reductase domain fragment (amino acids 645-850) that partially overlaps with the FAD binding domain of eNOS. A recombinant form of the SH3-containing protein Fyn competes the binding of recombinant eNOS protein with dyn-2 PRD, thereby implicating the SH3-like region contained within this reductase domain fragment as the dyn-2 binding region. Mammalian two-hybrid screen corroborates these interactions in cells as well. Functional studies demonstrate that dyn-2 PRD selectively potentiates eNOS activity in a concentration-dependent manner in an order of magnitude similar to that observed with dyn-2 full-length and in a manner that requires calmodulin. Although dyn-2 PRD does not influence eNOS oxygenase domain function or ferricyanide reduction, it does potentiate the ability of recombinant eNOS to reduce cytochrome c, supporting an influence of dyn-2 PRD on electron transfer between FAD and FMN. (These data indicate that the binding domains of dyn-2 and eNOS reside within the dyn-2 PRD domain and the FAD binding region of the eNOS reductase domains, respectively, and that dyn-2 PRD is sufficient to mediate dyn-2-dependent potentiation of eNOS activity, at least in part, by potentiating electron transfer.)


* This work was supported by National Institutes of Health Grants DK-02529, DK-59998, and DK-59615 (to V. S.), a grant from the Northland Affiliate of the American Heart Association (to V. S.), a fellowship grant from the Northland Affiliate of the American Heart Association (to S. C.), and by the Mayo Clinic Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: GI Research Unit, Alfred 2-435, Mayo Clinic, 200 First St. SW, Rochester, MN 55905. Tel.: 507-255-5040 or 6318; Fax: 507-255-5040 or 6318; E-mail: shah.vijay@mayo.edu.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Ji, G. Ferracci, A. Warley, M. Ward, K.-Y. Leung, S. Samsuddin, C. Leveque, L. Queen, V. Reebye, P. Pal, et al.
beta-Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90
PNAS, May 22, 2007; 104(21): 8839 - 8844.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. Trushina, R. D. Singh, R. B. Dyer, S. Cao, V. H. Shah, R. G. Parton, R. E. Pagano, and C. T. McMurray
Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo
Hum. Mol. Genet., December 15, 2006; 15(24): 3578 - 3591.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. A. Maniatis, V. Brovkovych, S. E. Allen, T. A. John, A. N. Shajahan, C. Tiruppathi, S. M. Vogel, R. A. Skidgel, A. B. Malik, and R. D. Minshall
Novel Mechanism of Endothelial Nitric Oxide Synthase Activation Mediated by Caveolae Internalization in Endothelial Cells
Circ. Res., October 13, 2006; 99(8): 870 - 877.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
Z. Yang and X.-F. Ming
Recent advances in understanding endothelial dysfunction in atherosclerosis.
Clin. Med. Res., March 1, 2006; 4(1): 53 - 65.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Icking, S. Matt, N. Opitz, A. Wiesenthal, W. Muller-Esterl, and K. Schilling
NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS
J. Cell Sci., November 1, 2005; 118(21): 5059 - 5069.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Cao, M. E. Fernandez-Zapico, D. Jin, V. Puri, T. A. Cook, L. O. Lerman, X.-Y. Zhu, R. Urrutia, and V. Shah
KLF11-mediated Repression Antagonizes Sp1/Sterol-responsive Element-binding protein-induced Transcriptional Activation of Caveolin-1 in Response to Cholesterol Signaling
J. Biol. Chem., January 21, 2005; 280(3): 1901 - 1910.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Chatterjee, S. Cao, T. E. Peterson, R. D. Simari, and V. Shah
Inhibition of GTP-dependent vesicle trafficking impairs internalization of plasmalemmal eNOS and cellular nitric oxide production
J. Cell Sci., September 1, 2003; 116(17): 3645 - 3655.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Hendrickson, S. Chatterjee, S. Cao, M. M. Ruiz, W. C. Sessa, and V. Shah
Influence of caveolin on constitutively activated recombinant eNOS: insights into eNOS dysfunction in BDL rat liver
Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G652 - G660.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.